Abstract
Immunotherapy for treatment of diseases of the central nervous system (CNS) has garnered significant interest, especially since the discovery of the lymphatic circulation and immune cell trafficking. Multiple immunomodulatory methods are under development for neurodegenerative and inflammatory diseases of the CNS, but the most active area of study is focused on brain tumors. In this chapter, we provide an overview of immunotherapy strategies while providing a critical assessment of those that hold the most promise. Notably, although most immunotherapy clinical trials have focused on glioblastoma, recent data suggest that other types of CNS malignancies and disorders may be amenable to immune therapeutic strategies, several of which demonstrate promise. However, further investigation is required to overcome the heterogeneity of these tumors and their continuous shift to resistance mechanisms.
Original language | English (US) |
---|---|
Title of host publication | Nervous System Drug Delivery |
Subtitle of host publication | Principles and Practice |
Publisher | Elsevier |
Pages | 297-334 |
Number of pages | 38 |
ISBN (Electronic) | 9780128139981 |
ISBN (Print) | 9780128139974 |
DOIs | |
State | Published - Jun 25 2019 |
Keywords
- Active immunotherapy
- Alzheimer disease
- Antibodies
- Cell therapies
- Cytokines
- Glioma
- Headaches
- Immune biologics
- Immune checkpoint inhibitors
- Immunomodulation
- Multiple sclerosis
- Virotherapy
ASJC Scopus subject areas
- General Medicine